On January 4, 2021 Emergent BioSolutions Inc. (NYSE: EBS) reported that members of the company’s executive management team will participate in the following investor conferences in the first quarter of 2021 (Press release, Emergent BioSolutions, JAN 4, 2021, View Source [SID1234573387]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

39th Annual J.P. Morgan Healthcare Conference
January 11 to 14, 2021
Company presentation scheduled on January 11 at 8:20am EST

J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference
March 1 to 3, 2021
Presentation date and time will be updated on the Emergent website as the information becomes available.

Cowen 41st Annual Health Care Conference
March 1 to 4, 2021
Presentation date and time will be updated on the Emergent website as the information becomes available.
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company’s recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.